UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of Earliest Event Reported): May 15, 2008
 
STAAR Surgical Company
(Exact name of registrant as specified in its charter)
 
Delaware
(State or other jurisdiction
of incorporation)
0-11634
(Commission File Number)
95-3797439
(I.R.S. Employer
Identification No.)
     
1911 Walker Ave, Monrovia, California
(Address of principal executive offices)
 
91016
(Zip Code)

Registrant’s telephone number, including area code:  626-303-7902
 
                                    Not Applicable                                    
Former name or former address, if changed since last report
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 
 
o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 

 
 
Item 8.01 Other Events
 
Submission of Matters to a Vote of Security Holders
 
a.
The annual meeting of the stockholders of the Company (the “Annual Meeting”) was held on May 15, 2008.

b.
At the Annual Meeting each of the six nominated candidates for director was elected to serve until the annual meeting of stockholders in 2009 and until his successor is duly elected and qualified. The vote was as follows:

 
Number of Shares
For
Withheld
Don Bailey
23,708,693
698,705
David Bailey
19,594,177
4,813,221
Barry Caldwell
23,856,937
550,461
Donald Duffy
20,235,214
4,172,184
John C. Moore
23,832,837
574,561
David Morrison
20,531,078
3,876,320
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
May 20, 2008
STAAR Surgical Company
 
 
 
 
 
 
  By:   /s/ Barry Caldwell
 
Barry Caldwell
 
President and Chief Executive Officer